SCUTERI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.400
AS - Asia 846
EU - Europa 811
AF - Africa 96
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.193
Nazione #
US - Stati Uniti d'America 1.380
SG - Singapore 321
CN - Cina 226
GB - Regno Unito 187
SE - Svezia 155
VN - Vietnam 133
DE - Germania 132
IT - Italia 123
HK - Hong Kong 71
TG - Togo 44
IN - India 40
RU - Federazione Russa 38
IE - Irlanda 35
BR - Brasile 31
NL - Olanda 29
FR - Francia 28
BE - Belgio 22
JO - Giordania 20
CI - Costa d'Avorio 19
ZA - Sudafrica 16
EE - Estonia 15
KR - Corea 12
CA - Canada 11
BG - Bulgaria 9
UA - Ucraina 9
FI - Finlandia 8
GR - Grecia 6
ID - Indonesia 6
MX - Messico 6
NG - Nigeria 6
SC - Seychelles 6
CH - Svizzera 5
IR - Iran 5
AT - Austria 4
JP - Giappone 4
AR - Argentina 3
EC - Ecuador 2
EG - Egitto 2
PL - Polonia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
GL - Groenlandia 1
GT - Guatemala 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.193
Città #
Singapore 236
Ashburn 190
Southend 175
Chandler 159
Fairfield 126
Ann Arbor 74
Hong Kong 69
Dong Ket 61
Seattle 61
Wilmington 57
Woodbridge 56
Houston 52
Cambridge 47
Lomé 44
Santa Clara 44
Princeton 41
Dublin 35
Beijing 33
Boardman 33
Dallas 31
Hefei 23
Nanjing 23
Brussels 22
Bologna 21
Amman 20
Bremen 20
Abidjan 19
Turin 19
Hanoi 18
Westminster 18
Munich 17
Ho Chi Minh City 16
New York 15
Padova 15
Los Angeles 14
Buffalo 13
Jinan 11
San Diego 11
Seoul 11
Changsha 10
Dearborn 10
Saint Petersburg 10
Berlin 9
Falkenstein 9
Redondo Beach 9
Rome 9
Sofia 9
Frankfurt am Main 8
Des Moines 7
Dolo 7
Florence 7
Jiaxing 7
Medford 7
Shenyang 7
Abeokuta 6
Helsinki 6
Redmond 6
Toronto 6
Yubileyny 6
Zola Predosa 6
Amsterdam 5
Milan 5
Falls Church 4
Hebei 4
Mexico City 4
Nanchang 4
Phoenix 4
Tokyo 4
Vienna 4
Chengdu 3
Chicago 3
Guangzhou 3
Haiphong 3
Hyderabad 3
Kunming 3
Norwalk 3
Roubaix 3
Stockholm 3
São Paulo 3
Washington 3
Wuhan 3
Zhengzhou 3
Ardabil 2
Bengaluru 2
Bern 2
Brooklyn 2
Castel Maggiore 2
Charlotte 2
Châtenay-Malabry 2
Düsseldorf 2
Foshan 2
Gargnano 2
Hải Dương 2
Lanzhou 2
Las Vegas 2
Monmouth Junction 2
Ningbo 2
Nuremberg 2
Olalla 2
Piandimeleto 2
Totale 2.224
Nome #
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients. 191
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 191
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study. 179
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 172
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 172
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 170
A Case of Acute Liver Failure during Ritonavir-Boosted Paritaprevir, Ombitasvir and Dasabuvir Therapy in a Patient with HCV Genotype 1b Cirrhosis 164
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 163
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 152
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 151
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 149
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 146
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 145
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 140
Two years Mycophenolate Mofetil plus low dose calcineurin inhibitor for renal dysfunction after liver transplantation. 133
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 125
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 108
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 108
null 107
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 107
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 99
null 92
Psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects 90
Totale 3.254
Categoria #
all - tutte 8.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021169 0 0 0 0 0 3 8 20 19 18 9 92
2021/2022457 36 26 28 32 37 24 6 21 12 60 113 62
2022/2023630 52 103 32 93 39 63 8 30 102 17 60 31
2023/2024136 14 22 12 15 10 31 6 5 3 6 2 10
2024/2025495 18 54 33 62 59 23 28 26 16 35 26 115
2025/2026607 116 70 110 80 181 50 0 0 0 0 0 0
Totale 3.254